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Prolonged mechanical ventilation (MV) results in 
oxidative damage in the diaphragm; however, it is unclear 
whether this MV-induced oxidative injury occurs rapidly or 
develops slowly over time. Furthermore, it is unknown 
whether both soluble (cytosolic) and insoluble 
(myofibrillar) proteins are equally susceptible to oxidation 
during MV. These experiments tested two hypotheses: 1) 
MV-induced oxidative injury in the diaphragm occurs within 
the first 6 h after the initiation of MV; and 2) MV is associ- 
ated with oxidative modification of both soluble and insoluble 
proteins. Adult Sprague-Dawley rats were randomly divided 
into one of seven experimental groups: 1) control (n = 8); 2) 
3-h MV (n = 8); 3) 6-h MV (n = 6); 4) 18-h MV (n = 8); 5) 3-h 
anesthesia-spontaneous breathing (n = 8); 6) 6-h anesthesia- 
spontaneous breathing (n = 6); and 7) 18-h anesthesia- 
spontaneous breathing (n = 8). Markers of oxidative injury in 
the diaphragm included the measurement of reactive (pro- 
tein) carbonyl derivatives (RCD) and total lipid hydroperox- 
ides. Three hours of MV did not result in oxidative injury in 
the diaphragm. In contrast, both 6 and 18 h of MV promoted 
oxidative injury in the diaphragm, as indicated by increases 
in both protein RCD and lipid hydroperoxides. Electro- 
phoretic separation of soluble and insoluble proteins indi- 
cated that the MV-induced accumulation of RCD was limited 
to insoluble proteins with molecular masses of ~200, 120, 80, 
and 40 kDa. We conclude that MV results in a rapid onset of 
oxidative injury in the diaphragm and that insoluble proteins 
are primary targets of MV-induced protein oxidation. 
respiratory muscles; muscle atrophy; free radicals; protein 
oxidation; weaning from mechanical ventilation; muscle in- 
jury 
MECHANICAL VENTILATION (MV) is used to maintain ven- 
tilation in patients who are incapable of maintaining 
adequate alveolar ventilation on their own. Respira- 
tory failure, neuromuscular diseases, drug overdoses, 
and recovery from general anesthetics are common 
indications for the use of MV (9). Problems in weaning 
patients after prolonged MV have been reported in a 
large number of individuals, and it is postulated that a 
common cause of difficult weaning is diaphragmatic 
force and endurance deficits (2, 11, 31–33). This notion 
is strongly supported by several recent animal studies 
demonstrating that controlled MV is associated with 
significant diaphragmatic atrophy and contractile dys- 
function (1, 13, 19, 22, 27–29). 
Our laboratory has recently discovered that 18 h of 
controlled MV results in an increase in oxidized pro- 
teins in the diaphragm, as indicated by elevated 
protein carbonyls (29). In the context of MV-induced 
diaphragmatic atrophy, an increase in protein oxida- 
tion is important, because moderately oxidized pro- 
teins are sensitive to proteolytic attack by the protea- 
some pathway of protein degradation (reviewed in 
Refs. 4 and 30). Therefore, oxidative modification of 
proteins could accelerate protein degradation in the 
diaphragm, resulting in diaphragmatic atrophy during 
prolonged MV. 
Of further interest is the possibility that the oxida- 
tive modification of diaphragm proteins contributes to 
the MV-induced diaphragmatic force deficit. Indeed, it 
is well established that oxidative stress in skeletal 
muscle can modify several proteins associated with 
excitation-contraction coupling and contribute to a re- 
duction in muscle force production (reviewed in Refs. 
17, 24–26). Therefore, oxidative injury in the dia- 
phragm could have important implications in the eti- 
ology of both MV-induced atrophy and contractile def- 
icits in the diaphragm. 
At present, numerous questions associated with MV- 
induced diaphragmatic oxidative injury remain unan- 
swered. For example, it is unknown whether MV-in- 
duced oxidative injury occurs within the first 6 h of MV 
or develops slowly over time. Furthermore, it is unclear 
which diaphragmatic proteins are oxidatively modified 
during MV. Therefore, the objectives of this experi- 
ment were twofold: 1) to determine whether oxidative 
modification of diaphragmatic proteins occurs rapidly 
after the initiation of MV; and 2) to establish whether 
both  soluble  and  insoluble  proteins  are  oxidatively 
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modified during MV. On the basis of evidence that 
immobilization of locomotor skeletal muscles results in 
progressive oxidative injury in muscle fibers (12), we 
hypothesized that MV-induced oxidative injury in the 
diaphragm would develop gradually within the first 6 h 
of MV. Furthermore, we hypothesized that MV-in- 
duced oxidative damage in the diaphragm would target 
both soluble and insoluble proteins in skeletal muscle. 
This postulate evolved from a report indicating a dif- 
ferential susceptibility of soluble and insoluble skeletal 
muscle proteins to free radical damage (7). 
METHODS 
 
Experimental Animals 
These experiments were approved by the University of 
Florida animal use committee and followed the guidelines 
for animal experiments established by the American Physi- 
ological Society. Healthy, young adult (female, 4-mo-old) 
Sprague-Dawley rats were individually housed and fed rat 
chow and water ad libitum and were maintained on a 12:12-h 
light-dark cycle for 3 wk before initiation of these experi- 
ments. 
Experimental Design 
To examine the time  course of MV-induced contractile 
dysfunction in the diaphragm, animals were randomly as- 
signed to one of seven experimental groups (Fig. 1). 
Protocol for control animals. The animals in the control 
group were free of intervention before measurement of dia- 
phragmatic biochemical properties. That is, these animals 
were not mechanically ventilated or exposed to long-term 
anesthesia before study. Animals in the control group re- 
ceived an intraperitoneal (IP) injection of pentobarbital so- 
dium (50 mg/kg body wt). After a surgical plane of anesthesia 
was achieved, the diaphragm was rapidly removed, and seg- 
ments from the ventral costal region were rapidly frozen in 
liquid nitrogen and stored at -80°C for subsequent analysis 
of oxidant damage. 
Protocol for anesthetized, spontaneously breathing ani- 
mals. To determine whether long-term anesthesia (i.e., pen- 
tobarbital sodium) impairs diaphragmatic contractile prop- 
erties, our experimental design included three groups of 
anesthetized, spontaneously breathing (SB) animals. Se- 
lected diaphragmatic biochemical properties were studied 
after 3, 6, or 18 h of SB. Animals were anesthetized with an 
IP injection of pentobarbital sodium (50 mg/kg), and, after a 
surgical plan of anesthesia was reached, a venous catheter 
was inserted in the jugular vein to permit the infusion of 
isotonic saline and pentobarbital sodium when necessary. 
Animals were then tracheostomized, and a surgical plane of 
anesthesia was maintained throughout the experimental pe- 
riod by constant infusion of pentobarbital sodium (~10 
mg · kg-1 · h-1). An arterial catheter was placed in the carotid 
artery, and arterial blood samples (~100 µl/sample) were 
removed during the first and last hour from each experimen- 
tal group. Arterial blood samples were analyzed for arterial 
PCO2 (PaCO2), PO2 (PaCO2), and pH by using a blood-gas 
analyzer (Instrumentation Laboratories, model 1610). Before 
analysis, the analyzer was calibrated by using standardized 
gases and pH solutions. To avoid infection, strict aseptic 
techniques were used during all invasive procedures. 
Body temperature was maintained at ~37°C by use of a 
recirculating heating blanket. Animals in the SB groups were 
constantly monitored by a technician and received continu- 
ing care. Continuing care during anesthesia of the experi- 
mental groups included expressing the bladder, removing 
upper airway mucus, lubricating the eyes, rotating the ani- 
mal, and passive movement of the limbs. This care was 
maintained throughout the experimental period at 1-h inter- 
vals. Furthermore, both heart rate and blood pressure were 
measured and recorded at 1-h intervals throughout the ex- 
periment. Finally, to reduce airway secretions, animals in 
the SB groups received intramuscular injections of glyco- 
pyrrolate (0.04 mg/kg) every 2 h. 
Throughout the period of SB, animals received enteral 
nutrition by use of the American Institute of Nutrition-76 
rodent diet with a nutrient composition of 15% proteins, 35% 
lipids, 50% carbohydrates, and vitamins and minerals (Re- 
search Diets, Brunswick, NY). Our planned feeding schedule 
was designed to provide an isocaloric diet with the nutrients 
administered every 2 h via a gastric tube; the total daily 
administration of 69 ml is equivalent to 69 kcal/day. Body 
fluid homeostasis was maintained via the administration of 
2.0-ml · kg-1 · h-1 intravenous electrolyte solution. On com- 
pletion of the prescribed time period of SB (i.e., 3, 6, or 18 h), 
segments of the costal diaphragm were removed and rapidly 
frozen in liquid nitrogen and stored at -80°C for subsequent 
analysis of oxidant damage. 
Protocol for mechanically ventilated animals. All surgical 
procedures were performed by using the aseptic technique. 
Animals randomly selected for MV were anesthetized with 
an IP injection of pentobarbital sodium (50 mg/kg body wt). 
After reaching a surgical plane of anesthesia, the animals 
were tracheostomized and mechanically ventilated by using 
a volume-driven, small-animal ventilator (Harvard Appara- 
tus, Cambridge, MA). The ventilator delivered all breaths; 
hence, this mode of ventilation (i.e., controlled MV) results in 
complete diaphragmatic inactivity. The tidal volume was 
established at ~1 ml/100 g body wt, with a respiratory rate of 
80 breaths/min. This respiratory rate was selected to mimic 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Schematic illustration of the 
experimental design used in these ex- 
periments. SB, spontaneously breath- 
ing; MV, mechanically ventilated. 
 
 
 
the breathing frequency of adult rats at rest. Additionally, 
positive end-expiratory pressure (PEEP) of 1 cmH2O was 
used throughout the protocol. 
An arterial catheter was placed in the carotid artery for 
constant measurement of blood pressure and periodic blood 
sampling for analysis of arterial pH and blood gases. Arterial 
blood samples (~100 µl/sample) were removed during the 
first and last hour of MV and analyzed for PaCO2, PaO2, and 
arterial pH by using a blood-gas analyzer (Instrumentation 
Laboratories, model 1610). Before analysis, the analyzer was 
calibrated by using standardized gases and pH solutions. 
A venous catheter was inserted in the jugular vein to 
permit the infusion of isotonic saline and pentobarbital so- 
dium when necessary. Anesthesia was maintained over the 
entire period of MV by continuous infusion of pentobarbital 
sodium (~10 mg/kg body wt). Note that we continuously 
monitored the level of anesthesia in our animals by several 
methods (i.e., monitoring heart rate, blood pressure, and 
corneal-lid reflexes). Body temperature was maintained at 
~37°C by use of a recirculating heating blanket. Addition- 
ally, heart rate and electrical activity of the heart were 
monitored via a lead II ECG by using needle electrodes 
placed subcutaneously. Identical to the SB experiments, 
strict aseptic techniques were used during all invasive pro- 
cedures. 
Throughout MV, animals received enteral nutrition by use 
of the aforementioned American Institute of Nutrition-76 
rodent diet. This planned feeding schedule was identical to 
the routine described for the SB animals. Furthermore, body 
fluid homeostasis was maintained via the administration of 
2.0 ml · kg-1 · h-1 intravenous electrolyte solution. 
Continuing care during MV included expressing the blad- 
der, removing airway mucus, lubricating the eyes, rotating 
the animal, and passive movement of the limbs. This care 
was maintained throughout the experimental period at 
hourly intervals. Finally, identical to the protocol used in the 
SB animals, repeated intramuscular injections of glycopyrro- 
late (0.04 mg · kg-1 · 2 h-1) were employed to reduce airway 
secretions. On completion of MV, segments of the costal 
diaphragm were removed, rapidly frozen in liquid nitrogen, 
and stored at -80°C for subsequent analysis of oxidant 
damage. 
 
Biochemical Measurements 
Measurement of reactive carbonyl derivatives. Oxidative 
modification of proteins by free radical species and other 
reactive species results in the formation of carbonyl groups 
into amino acid side chains by a site-specific mechanism. 
These carbonyl groups or reactive carbonyl derivatives (RCD) 
can be identified by using sensitive assays. The RCD in 
diaphragms from all experimental groups were determined 
by both spectrophotometry and immunoblot methods. The 
spectrophotometric assay was used to determine total RCD 
in diaphragm. Briefly, a section (25–45 mg) of the costal 
diaphragm was homogenized and assayed to quantitatively 
determine the levels of RCD in control, SB, and MV animals, 
as described by Reznick and Packer (26). 
To determine the molecular weights of oxidized proteins in 
the diaphragm, soluble and insoluble proteins were sepa- 
rated by centrifugation (11,000 g at 4°C for 10 min). Protein 
(2 µg) from the soluble and insoluble fractions were then 
individually separated via polyacrylamide gel electrophore- 
sis; RCD were then measured by Western blot by using a 
protocol recommended by the manufacturer (Intergen, Oxy- 
Blot protein oxidation detection kit, S7150, Purchase, NY). A 
brief overview of this protocol follows. 
The carbonyl groups in the protein side chains of both 
soluble and insoluble proteins were derivatized to 2,4-dini- 
trophyenylhydrazone (DNP). These DNP-derivatized protein 
samples were separated in duplicate by using polyacrylamide 
gel electrophoresis via 4–20% gradient polyacrylamide gels 
containing 0.1% SDS. After electrophoresis, the proteins 
were transferred  to  nitrocellulose membranes. The mem- 
branes were then soaked in PBS buffer containing 3% skim 
milk, 0.05% Tween, and 0.05% sodium azide and subse- 
quently incubated with a primary antibody, specific to the 
DNP moiety of the proteins. This step was followed by incu- 
bation with a horseradish peroxidase antibody conjugate 
directed against the primary antibody. The membranes were 
then treated with chemiluminescent reagents (luminol and 
enhancer) and exposed to light-sensitive film. Images of these 
films were captured and analyzed by using computerized 
image analysis (Gel Doc 2000, BioRad, Hercules, CA). The 
oxidative status of different molecular weight proteins was 
determined by comparing the signal intensity of the same 
protein in different lanes of the various gels. 
Furthermore, to determine the identity of selected oxidized 
proteins, membranes containing diaphragmatic insoluble 
proteins were stripped of the DNP antibody and were then 
reprobed with monoclonal antibodies specific for rat skeletal 
muscle actin and myosin heavy chains. More specifically, to 
determine whether the 40- and 200-kDa bands were actin 
and myosin, membranes were sequentially stripped and re- 
probed with actin monoclonal (anti-a-sarcomeric actin, clone 
5c5, no. A2172, Sigma Chemical, St. Louis, MO) and myosin 
monoclonal [anti-myosin heavy chain (all adult isoforms), 
clone A4.1025, DSHB, University of Iowa, Iowa City, IA] 
antibodies. Importantly, our laboratory has confirmed the 
specific reactivity of these monoclonal antibodies with the 
respective purified proteins. Membranes were incubated at 
37°C for 30 min with membrane-stripping buffer (Restore 
Western Blot Stripping Buffer, no. 21059, Pierce, Rockford, 
IL) followed by 1 h of blocking in PBS buffer containing 3% 
skim milk and 0.05% Tween. Myosin and actin antibodies 
were applied to membranes at concentrations of 1:500 and 
1:1,000 in blocking buffer, respectively, and incubated for 1 h. 
Membranes were rinsed twice and then washed with PBS 
buffer containing 0.05% Tween for 30 min before and after 
the secondary antibody incubation. The secondary antibody 
(anti-mouse, HRP conjugated) was diluted 1:2,000 in PBS 
containing 0.05% Tween and applied to the membrane for 
1 h. The membranes were treated with chemiluminescent 
reagents and exposed to light-sensitive film, as described 
above. 
Measurement of total lipid hydroperoxides. Assessment of 
lipid peroxidation in tissues can be estimated by measure- 
ment of tissue levels of total hydroperoxides. Tissue hy- 
droperoxides were determined by using the modifications of 
the ferrous oxidation/xylenol orange technique described by 
Hermes-Lima et al. (8). Details of these techniques are con- 
tained in previous reports from our laboratory (3, 17). In our 
hands, the within-day coefficient of variation for this assay is 
low (~5%), but the between-day coefficient of variation is 
considerably larger (~12%). Hence, because of experimental 
timing and the large number of samples to be assayed, by 
necessity, these assays were performed on different days. To 
reduce the between-day variability in these measurements, 
an equal number of diaphragm samples from control, SB, and 
MV samples was assayed on each day, and the total lipid 
hydroperoxide concentrations in both SB and MV dia- 
phragms were then normalized as a percentage of control. 
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Table 1. Animal body weights before and after the 
experimental treatments (i.e., spontaneous 
breathing or mechanical ventilation 
 
 
 
 
 
 
 
 
 
Values are means ± SD in g. SB, spontaneous breathing; MV, 
mechanical ventilation. No differences existed between the experi- 
mental groups before or after the experimental treatment. 
 
 
Statistical Analysis 
Comparisons between groups for each dependent variable 
measured were made by a two-way ANOVA. Significance was 
established at P < 0.05. Where significant differences ex- 
isted, a Scheffé test was used post hoc. 
 
RESULTS 
Systemic and Biological Response to MV 
One animal that completed the prescribed period of 
MV was eliminated from our analysis because post- 
mortem analysis revealed evidence of lung barotrauma 
and significant disturbance of blood-gas homeostasis. 
No animals were eliminated due to infection. Of the 
animals included in our analysis, initial and final body 
weights did not differ (P > 0.05) between the experi- 
mental groups. Note that 3–18 h of MV did not signif- 
icantly alter (P > 0.05) animal body weights (Table 1). 
These results confirm that our program of enteral 
nutrition and rehydration was adequate. 
To determine whether our MV protocol was success- 
ful in maintaining homeostasis, we measured arterial 
cate that the animals included in our analysis did not 
develop infections during MV or SB. This statement is 
supported by the observation that microscopic exami- 
nation of blood revealed no detectable bacteria, and 
postmortem examination of the lungs (visual) and peri- 
toneal cavity (visual) displayed no detectable abnor- 
malities. Furthermore, both our MV and SB animals 
were afebrile during the investigation. Finally, during 
the course of MV and SB, no significant (P > 0.05) 
changes occurred in the body weights of our animals. 
Collectively, these results indicate that the MV and SB 
animals used in our analysis were free of significant 
infection. 
Measurements of Diaphragmatic Oxidative Injury 
RCD. RCD were measured as a marker of protein 
oxidation in diaphragms from all experimental groups. 
Mean (±SE) levels of total RCD (nmol of RCD per mg 
of protein) in the costal diaphragm from all experimen- 
tal groups are contained in Fig. 2. No significant dif- 
ferences existed in total RCD (i.e., soluble and insolu- 
ble proteins) between control animals and the SB 
groups. However, compared with control and SB, only 
6 and 18 h of MV resulted in significant increases in 
the levels of total RCD in the diaphragm. Although 
RCD levels in diaphragms from 18-h MV animals 
tended to be greater than those from 6-h MV animals, 
these differences were not significant. 
Figure 3 contains two representative Western blots 
illustrating the RCD content in the costal diaphragm 
in a control animal vs. animals exposed to MV or SB. 
Computerized image analysis of these blots revealed 
that, compared with control and 18 h of SB, 18 h of MV 
resulted in significant increases in RCD in diaphrag- 
matic  insoluble  proteins  with  molecular  masses  of 
~200, 128, 85, and 40 kDa (Fig. 4). Similarly, com- 
pared with both control and 6 h of SB, 6 h of MV 
resulted in an increase in RCD in diaphragmatic insol- 
blood pressure, pH, and PaCO and PaO in all animals uble proteins with molecular masses of ~200, 128, and 
within the first hour of MV and during the final hour of 
MV. Our data indicate that adequate arterial blood 
pressure and blood gas/pH homeostasis were main- 
tained during MV. For example, PaO and PaCO during 
the last hour of MV in the 18-h MV animals ranged 
from 71–82 and 32–36 Torr, respectively. Systolic 
blood pressure and arterial pH ranged from 95 to 115 
mmHg and 7.42 to 7.45, respectively. Similar values 
were recorded in both the 3- and 6-h MV groups. 
In contrast to the MV animals, measurements of 
arterial blood-gas tensions and pH in the SB animals 
revealed that these animals experienced hypoxemia, 
hypercapnia, and mild acidosis during the experimen- 
tal period. For example, PaO and PaCO ranged from 45 
to 65 and 49 to 68 Torr, respectively, during the last 
hour of SB in the 3-, 6-, and 18-h SB animals. These 
disturbances in blood-gas homeostasis during anesthe- 
sia were likely due to hypoventilation resulting from 
depressed ventilatory drive. 
Because sepsis is associated with diaphragmatic con- 
tractile dysfunction, strict aseptic techniques were fol- 
lowed throughout the experiments. Our results indi- 
 
 
 
Fig. 2. Spectrophotometric analysis of the accumulation of total 
reactive carbonyl derivatives (RCD) in diaphragmatic insoluble pro- 
teins in all 7 experimental groups: 1) control (Con); 2)  3  h of SB 
(SB3); 3) 6 h of SB (SB6); 4) 18 h of SB (SB18); 5) 3 h of MV (MV3); 
6) 6 h of MV (MV6); and 7) 18 h of MV (MV18). Values are means ± 
SE. * Significantly different (P < 0.05) from Con, SB6, and SB18. 
 
Experimental Group Before Treatment After Treatment 
Control 296 ± 5  
SB-3 h 283 ± 7 284 ± 7 
MV-3 h 279 ± 6 282 ± 6 
SB-6 h 297 ± 12 295 ± 11 
MV-6 h 277 ± 6 276 ± 5 
SB-18 h 275 ± 11 266 ± 10 
MV-18 h 296 ± 15 293 ± 14 
 
 
 
 
 
Fig. 4. Analysis of Western blots of the accumulation of RCD within 
insoluble proteins in the diaphragm of Con, SB, and MV animals. 
Values are means ± SE of the optical densities. * Significantly 
different (P < 0.05) from Con, SB6, and SB18. # Significantly differ- 
ent (P < 0.05) from MV6. 
 
blots were stripped of the DNP antibody and were then 
sequentially reprobed for rat skeletal muscle actin and 
myosin heavy chains (all isoforms). These experiments 
revealed that the oxidized 200- and 40-kDa proteins 
were the contractile proteins myosin heavy chain and 
actin, respectively (Fig. 5). 
Lipid hydroperoxides. Tissue levels of lipid hydroper- 
oxides were assessed as markers of lipid peroxidation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Representative Western blots illustrating the level of RCD in 
diaphragmatic insoluble proteins with molecular masses ranging 
between 200 and 40 kDa. A: levels of RCD in diaphragmatic insolu- 
ble proteins in Con, SB6, and MV6. B: level of RCD in diaphragmatic 
insoluble proteins in Con, SB18, and MV18. 
 
85 kDa. Also, compared with 6  h of MV, 18 h of MV 
resulted in significantly higher RCD in insoluble dia- 
phragmatic proteins with molecular masses of ~200, 
128, and 40 kDa. Finally, no significant differences 
existed in RCD levels of soluble proteins at any molec- 
ular mass after MV (data not shown). 
To determine the identity of the oxidized insoluble 
proteins  in  the  diaphragm,  representative  Western 
 
 
Fig. 5. Illustration of Western blots using monoclonal antibodies to 
identify oxidized proteins with molecular masses of ~200 to 40 kDa. 
Left lane: RCD in insoluble proteins isolated from the diaphragm of 
an animal exposed to MV18. Middle  and right  lanes:  the  same 
membrane stripped of the 2,4-dinitrophyenylhydrazone antibody 
and then sequentially reprobed with monoclonal antibodies specific 
for rat skeletal muscle actin and all myosin heavy chain (MHC) 
isoforms. 
 
 
 
in the costal diaphragm. In agreement with the RCD 
data, no differences in diaphragmatic levels of lipid 
hydroperoxides existed between control and SB ani- 
mals. Furthermore, no differences existed in diaphrag- 
matic lipid hydroperoxide levels between control ani- 
mals and animals exposed to 3 h of MV (Table 2). In 
contrast, both 6 and 18 h of MV were associated with 
significant increases in diaphragmatic levels of lipid 
hydroperoxides (Table 2). Whereas diaphragmatic lev- 
els of lipid hydroperoxides tended to be greater in 18-h 
MV animals compared with 6-h MV animals, these 
differences did not reach statistical significance. 
DISCUSSION 
Overview of Principal Findings 
These experiments provide new and important infor- 
mation regarding both the time course of MV-induced 
oxidative injury in the diaphragm and unique details 
about the insoluble proteins that are preferentially 
oxidized. Our results reveal that MV-induced oxidative 
injury in the diaphragm does not occur rapidly after 
the onset of MV (i.e., <3 h of MV), but is present after 
6 h of MV. Furthermore, our data indicate that insol- 
uble proteins (molecular masses of ~200, 128, 85, and 
40 kDa) are differentially oxidized during controlled 
MV. The oxidized proteins with molecular masses of 40 
and 200 kDa were identified as being actin and myosin 
heavy chain, respectively. Collectively, these data sup- 
port the hypothesis that the onset of MV-induced dia- 
phragmatic oxidative injury occurs within 6 h after the 
onset of MV and that insoluble proteins are targets for 
oxidative modification. The biological and clinical sig- 
nificance of these results are discussed in the following 
sections. 
Biological Significance of MV-induced 
Oxidative Injury 
It is well established that radicals and other reactive 
oxygen species (ROS) are produced in both contracting 
and inactive skeletal muscles (12, 24). When ROS pro- 
duction in skeletal muscle is high enough to overwhelm 
biological antioxidant defense systems, oxidative 
stress occurs. In this regard, oxidants can alter the 
structure and function of lipids, proteins, and nucleic 
acids, leading to cellular injury and death (20). 
Oxidative injury in skeletal muscle is biologically 
important because oxidant stress can contribute to 
both muscle atrophy and contractile dysfunction (re- 
viewed in Refs. 18, 23–25). In the context of MV- 
induced diaphragmatic atrophy, protein oxidation is 
significant because oxidized proteins are sensitive to 
proteolytic attack by proteases (4, 30). Hence, it is 
possible that oxidative stress plays an important role 
in MV-induced atrophy of the diaphragm. 
Oxidative stress in skeletal muscles is also associ- 
ated with contractile dysfunction. Indeed, numerous 
investigators have demonstrated that oxidant stress 
results in depressed muscle force production at both 
submaximal and maximal stimulation frequencies 
(26). Although oxidant injury can impair the function 
of several skeletal muscle proteins associated with 
excitation-contraction coupling, the specific mecha- 
nism(s) responsible for the oxidant-induced force defi- 
cit in muscle is unclear and continues to be an active 
area of research. 
 
MV-induced Oxidative Injury: Sources of ROS 
Historically, it was believed that ROS production is 
relatively high in contracting skeletal muscle and low 
in noncontracting muscle. However, extensive work by 
Kondo et al. (12) has demonstrated that oxidative in- 
jury occurs in immobilized locomotor muscle, and this 
injury contributes to muscle atrophy. Similarly, the 
present experiments demonstrate that controlled MV 
leading to diaphragmatic inactivity results in oxidative 
injury in the diaphragm (Figs. 2 and 4; Table 2). Im- 
portantly, our experiments demonstrate that the oxi- 
dative damage in the diaphragm associated with MV is 
not due to the anesthetic, because protein oxidation 
does not occur in diaphragms of anesthetized, SB ani- 
mals (Fig. 2). 
Although our results clearly indicate that MV is 
associated with diaphragmatic oxidative injury, these 
experiments do not reveal the source(s) of ROS produc- 
tion. Pathways capable of producing ROS in skeletal 
muscle are numerous, and the pathways responsible 
for production of these oxidants are state dependent 
(reviewed in Ref. 10). For example, it is possible that 
the diaphragmatic oxidant production associated with 
MV could have occurred due to one or more of the 
following pathways: 1) generation of superoxide radi- 
cals by xanthine oxidase; 2) nitric oxide produced by 
nitric oxide synthase; 3) mitochondrial production of 
ROS; 4) ROS created by prostanoid metabolism in 
conjunction with increased phospholipase A2  activity; 
5) radical formation due to disruption of iron-contain- 
ing proteins; 6) radical generation by invading phago- 
cytic cells; and 7) NADPH oxidase. Kondo et al. (12) 
demonstrated that the oxidant production associated 
with immobilization of locomotor muscles was due, at 
least in part, to both the xanthine oxidase pathway and 
reactions involving reactive iron. Nonetheless, at 
present, the oxidant-producing pathways that are re- 
sponsible for MV-induced diaphragmatic oxidative in- 
 
Table 2. Effects of MV on diaphragmatic levels of total lipid hydroperoxides 
 
 3-h SB 3-h MV 6-h SB 6-h MV 18-h SB 18-h MV 
Total lipid hydroperoxides (%control) 0.4 ± 6.5 -10.7 ± 5.8 -3.8 ± 4.8 58.6 ± 8.1* 4.1 ± 5.7 71.8 ± 4.8* 
Values are means ± SE expressed as a percentage above or below the values of control animals (nonventilated animals). * Significantly 
different from control animals at P < 0.05. 
 
 
 
 
jury are unknown. This is an important area for future 
research. 
Time Course of MV-induced Oxidative Injury 
A new and important finding in this experiment was 
that MV-induced oxidative injury in the rat diaphragm 
occurs within 6 h after the initiation of MV. Based on 
the present data alone, it is unclear whether these 
findings can be extrapolated to humans. However, if a 
similar time course of MV-induced diaphragmatic oxi- 
dative injury exists in humans, our results would have 
important clinical implications that are applicable to 
numerous surgical procedures. Given the potential 
clinical significance of MV-induced diaphragmatic in- 
jury, this is an important area for future research. 
Although the present experiment is the first to ex- 
amine the time course of oxidative injury due to MV- 
induced inactivity in the diaphragm, previous experi- 
ments investigating locomotor skeletal muscle indicate 
that 8 days of immobilization are required to promote 
oxidative injury in the rat soleus muscle (12). Whereas 
both of these experimental models demonstrate that 
muscular inactivity is associated with oxidative stress, 
it is important to note that there are significant differ- 
ences between these two experimental paradigms (i.e., 
immobilization vs. MV). Indeed, during controlled MV, 
both the right and left hemidiaphragm are not con- 
tracting (19) but are undergoing repetitive passive 
shortening during mechanical expansion of the lungs 
(5). In contrast, immobilization of the soleus muscle 
does not permit muscle shortening. At present, it is 
unknown whether the rate and types of oxidant pro- 
duction are similar in immobilized muscles compared 
with mechanically inactive and passively shortened 
muscles. This is an important topic that warrants 
further study. 
 
Differential Protein Oxidation in the Diaphragm 
During MV 
Our results indicate that MV-induced protein oxida- 
tion in the diaphragm occurs in insoluble proteins. In 
contrast, no evidence of protein oxidation was found in 
soluble proteins within the diaphragm. There are at 
least three explanations for this differential response 
in MV-induced protein oxidation. First, it is possible 
that, compared with soluble proteins, the cellular 
site(s) of ROS formation favored the oxidation of insol- 
uble proteins. Second, it has been postulated that the 
antioxidant capacity is greater in the cytosol compared 
with other regions of the cell (21). In this case, com- 
pared with other cellular areas (e.g., mitochondria), the 
cytosol would be better protected against oxidative 
stress. Finally, it is possible that cytosolic proteins 
were oxidized during MV, but these damaged proteins 
were rapidly degraded by proteases. Therefore, if these 
oxidized proteins were degraded quickly after their 
formation, they would go undetected in the analysis of 
RCD. This notion has received support from Radak et 
al. (21). These investigators hypothesized that the abil- 
ity of the cytosol to remove oxidatively modified pro- 
teins is greater than that of other portions of the cell, 
because the cytosol hosts the proteasome complex, 
which is the primary protease that catabolizes oxida- 
tively modified proteins (4, 30). 
In regard to oxidative damage to specific insoluble 
proteins, our results reveal that 18 h of MV resulted in 
significant oxidation of insoluble proteins at molecular 
masses of ~200, 128, 85, and 40 kDa, as indicated by 
increases in the levels of RCD. Although one-dimen- 
sional electrophoresis alone does not permit the iden- 
tification of individual proteins, recognition of the mo- 
lecular weight of oxidized muscle proteins, along with 
monoclonal antibody binding to specific proteins, per- 
mits identification. For example, a previous study mea- 
suring muscle protein content via Western blot analy- 
ses has identified the myosin heavy chains as being the 
predominant 200-kDa protein in skeletal muscle (15). 
Furthermore, based on the primary structure (i.e., 
amino acid content), along with the secondary and 
tertiary structure of myosin, it has been argued that 
this protein is highly susceptible to oxidation and the 
formation of carbonyl groups (7). Therefore, on the 
basis of these results and our findings using a mono- 
clonal antibody against myosin heavy chains, we pos- 
tulate that the increase in RCD in 200-kDa proteins 
within diaphragms from MV animals was due to the 
oxidation of the myosin heavy chain subunit of native 
myosin. 
MV was also associated with significant increases in 
RCD in diaphragmatic proteins with molecular masses 
of ~128 kDa. A search of protein structure databases 
reveals that numerous 128-kDa proteins exist in skel- 
etal muscle, with the most common proteins being 
membrane-bound proteins or myosin binding proteins. 
Therefore, due to the large variety of 128-kDa proteins 
in skeletal muscle, the present study does not permit 
speculation about the identity of specific 128-kDa pro- 
teins that were oxidized in diaphragms from MV ani- 
mals. 
Our results also indicate that MV was associated 
with significant increases in RCD in diaphragmatic 
proteins at molecular masses of ~85 kDa. Although 
several skeletal muscle proteins have molecular 
masses of ~85 kDa, Radak et al. (21) have argued 
that the primary ~85-kDa skeletal muscle protein 
that is oxidized during exercise is aconitase (EC 
4.2.1.3). Aconitase is a mitochondrial enzyme that 
functions in the Krebs cycle (i.e., converts citrate 
into isocitrate). Furthermore, in vitro experiments 
reveal that aconitase is particularly sensitive to ox- 
idant stress and the formation of protein carbonyls 
(34). Nonetheless, based on the present data alone, it 
is unclear whether aconitase is a primary target of 
oxidation in the diaphragm during MV. 
Finally, MV also resulted in significant increases in 
RCD in diaphragmatic proteins with molecular masses 
of ~40 kDa. Several studies have identified the con- 
tractile protein actin as the predominant 40-kDa pro- 
tein in skeletal muscle (6, 15). Importantly, it has also 
been reported that actin is susceptible to oxidation 
when exposed to ROS (6). Therefore, due to both abun- 
 
 
 
dance and susceptibility to oxidation, actin is a strong 
candidate for a muscle protein to contain RCD at this 
molecular weight. Our data using a monoclonal anti- 
body against skeletal muscle actin support this conclu- 
sion. 
Critique of Experimental Model 
Because of the invasive nature of removing dia- 
phragm samples, animal models must be used to study 
the effects of MV on respiratory muscle biochemistry. 
Considerations in the choice of an animal model in- 
clude both practical considerations (e.g., size of the 
animal) and the applicability of the animal model to 
humans. In this regard, we chose the rat model for 
several reasons. First, adult rats are of adequate size 
to permit surgical procedures and removal of several 
arterial blood samples for blood-gas analysis during 
prolonged MV. Furthermore, and most importantly, 
human and rat diaphragms are similar in fiber-type 
composition, gross anatomic features, and function 
(14, 16). 
Many adult patients requiring MV are maintained 
on some form of pressure-assist MV. To investigate the 
effects of prolonged MV on diaphragmatic oxidative 
injury, we chose to use controlled MV, because this 
mode of MV results in no diaphragmatic contractile 
activity and because controlled MV has relevance in 
several clinical situations. For example, controlled MV 
is used in adult patients in numerous circumstances 
(e.g., drug overdose, spinal cord injury, and surgery) 
and is also commonly used in pediatric patients (9). 
Finally, we chose pentobarbital sodium as the gen- 
eral anesthetic in these experiments because of direct 
evidence that this anesthetic does not promote oxida- 
tive injury in the diaphragm or negatively impact dia- 
phragm atrophy or contractile function (19, 28, 29). 
Conclusions and Future Directions 
These experiments support the hypothesis that the 
onset of MV-induced diaphragmatic oxidative injury is 
rapid and that insoluble proteins are targets for oxida- 
tive modification. Indeed, MV-induced protein oxida- 
tion was evident in insoluble proteins in the diaphragm 
with molecular masses of 200, 128, 85, and 40 kDa. 
Although our experiments do not reveal the identity of 
all of the specific proteins that are oxidized during MV, 
based on antibody identification, we postulate that 
diaphragmatic actin (40 kDa) and myosin (200 kDa) 
are strong candidates for oxidation during MV. If one 
or both of these contractile proteins are oxidatively 
damaged during MV, it is conceivable that this type of 
oxidative injury could contribute to both the decrease 
in contractile proteins and the force-generating capac- 
ity in the diaphragm observed after MV. This is an 
interesting possibility and should be addressed in fu- 
ture experiments. 
Finally, our data also reveal that oxidative injury in 
the diaphragm occurs within the first 6 h after the 
onset of MV. At present, the sources of oxidant produc- 
tion within the diaphragm during MV are unknown. 
Knowledge about the specific pathways responsible for 
MV-induced diaphragmatic oxidant production would 
provide important information to develop countermea- 
sures to reduce or prevent MV-mediated oxidative 
stress in this primary inspiratory muscle. 
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